Archives
Influenza Hemagglutinin (HA) Peptide: Precision Tag for P...
Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Purification and Detection
Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-amino acid tag derived from the influenza virus hemagglutinin protein, enabling specific detection and purification of HA-tagged proteins in molecular biology workflows (APExBIO). It exhibits high solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL), supporting diverse buffer systems. The peptide competitively binds to Anti-HA antibodies, facilitating the elution of HA-tagged fusion proteins during immunoprecipitation (Dong et al., 2025). Its purity (>98%) is validated by HPLC and mass spectrometry. Proper storage (desiccated at -20°C) ensures stability and reproducibility across applications.
Biological Rationale
The HA tag was originally derived from the human influenza hemagglutinin protein, specifically from its epitope region. Epitope tags such as HA enable the detection, purification, and quantification of recombinant proteins without requiring custom antibodies for each new protein construct (Related Review). The HA tag sequence (YPYDVPDYA) is recognized with high specificity by monoclonal Anti-HA antibodies. This specificity underpins its widespread adoption in molecular biology, immunoprecipitation, and protein-protein interaction studies (See also).
Mechanism of Action of Influenza Hemagglutinin (HA) Peptide
The Influenza Hemagglutinin (HA) Peptide serves as a competitive ligand for Anti-HA antibodies. In immunoprecipitation assays, the HA peptide can be introduced to specifically displace HA-tagged proteins from the antibody or affinity matrix. This mechanism relies on the peptide's high affinity for the antibody binding site, which mimics the epitope recognized in HA-tagged proteins. The result is a gentle and specific elution of bound proteins under non-denaturing conditions (APExBIO). Such competitive elution preserves protein function and complex integrity, which is critical for downstream functional assays or interaction studies. The peptide's solubility in aqueous and organic solvents allows flexible integration into different buffer systems for immunoprecipitation or Western blotting workflows (Contrast: This article extends on technical solubility benchmarks for HA tag peptide use).
Evidence & Benchmarks
- HA tag sequence (YPYDVPDYA) enables sensitive detection and purification of fusion proteins in a variety of host systems (Dong et al., 2025).
- Competitive elution with synthetic HA peptide preserves protein-protein and protein-complex integrity better than low-pH or denaturing elution methods (DOI:10.1002/advs.202504704).
- Solubility data: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water under ambient conditions, allowing broad buffer compatibility (APExBIO).
- Purity >98% as confirmed by HPLC and mass spectrometry ensures reproducibility in biochemical assays (APExBIO).
- Applications validated in studies of ubiquitination and the AKT/mTOR pathway using HA-tagged constructs and competitive elution strategies (Dong et al., 2025).
Applications, Limits & Misconceptions
The HA tag is routinely used in:
- Immunoprecipitation (IP) and co-immunoprecipitation (co-IP) of HA-tagged fusion proteins.
- Western blot detection, immunofluorescence, and immunocytochemistry using Anti-HA antibodies.
- Competitive elution of HA fusion proteins from magnetic beads or agarose matrices.
- Mapping protein-protein interactions and studying post-translational modifications, including ubiquitination (This article focused on HA peptide in ubiquitination; here, we expand on purification dynamics).
Common Pitfalls or Misconceptions
- The HA peptide tag does not confer solubility to poorly soluble proteins; its solubility refers to the peptide itself.
- Anti-HA antibodies may show cross-reactivity in rare cases; validation with appropriate controls is necessary.
- Improper storage (e.g., in solution at room temperature) can lead to peptide degradation and reduced performance.
- The peptide is not suitable for eluting proteins tagged with non-HA epitopes (e.g., FLAG, Myc).
- Overuse of peptide in elution can lead to antibody inactivation or increased background in some assays.
Workflow Integration & Parameters
The Influenza Hemagglutinin (HA) Peptide (A6004, APExBIO) is supplied as a lyophilized powder with >98% purity. For optimal use:
- Reconstitute the peptide in DMSO, ethanol, or water to desired working concentration (common: 1 mg/mL – 10 mg/mL).
- Store lyophilized peptide desiccated at -20°C; avoid repeated freeze-thaw cycles and extended storage of solutions.
- During IP, add HA peptide (typically 1–2 mg/mL final concentration) to compete off HA-tagged proteins for gentle, specific elution.
- Monitor elution by Western blot using Anti-HA antibody to confirm efficient competition and release.
- Buffers should be compatible with downstream applications and not contain denaturants or proteases.
This workflow ensures preservation of protein complexes and activity, enabling downstream biochemical or cell-based assays (Compared to previous reviews, this article details storage and solution handling for maximal peptide activity).
Conclusion & Outlook
The Influenza Hemagglutinin (HA) Peptide is a cornerstone reagent for molecular biology, enabling robust, high-specificity purification and detection of HA-tagged proteins. Its competitive binding mechanism ensures gentle and efficient elution, preserving protein integrity for advanced studies, including those focused on protein-protein interaction and post-translational modification pathways. The product's validated purity, solubility, and performance—combined with best practice handling—support reproducible results in research and development. For further technical details and ordering, see the official APExBIO Influenza Hemagglutinin (HA) Peptide page.